Naloxone potentiates the effects of subeffective doses of anxiolytic agents in mice

European Journal of Pharmacology

Volumn 323, Issue 2-3, 1997, Pages 133-136

  Belzung, Catherine ^a   Ågmo, Anders ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Benzodiazepine; Buspirone; Elevated plus maze test; Mouse; Opioid

Indexed keywords

ANXIOLYTIC AGENT; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; NALOXONE; OPIATE ANTAGONIST;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTI-ANXIETY AGENTS; BUSPIRONE; CHLORDIAZEPOXIDE; DIAZEPAM; DRUG SYNERGISM; MALE; MAZE LEARNING; MICE; NALOXONE; NARCOTIC ANTAGONISTS;

EID: 0343683388     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00142-8     Document Type: Article

References (15)

1. Cohen, G.A., Doze, V.A., Madison, D.V., 1992. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 9, 325.
2. Forchetti, C.M., Meek, J.L., 1981. Evidence for a tonic GABAergic control of serotonin neurons in the midbrain raphe nucleus. Brain Res. 206, 208.
3. Guidotti, A., Saiani, L., Wise, B.C., Costa, E., 1983. Cotransmitters: pharmacological implications. J. Neural. Transm. (Suppl.) 18, 213.
4. Haefely, W., 1994. Benzodiazepines, benzodiazepine receptors, and endogenous ligands. In: Den Boer, J.A., Sitsen, J.M. (Eds.), Handbook of Depression and Anxiety. Plenum, New York, NY, p. 573.
5. Harlin, R.E., Shivers, B.D., Romano, G.J., Howells, R.D., Pfaff, D.W., 1987. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J. Comp. Neurol. 258, 159.
6. Klitenick, M.A., Wirtshafter, D., 1989. Elicitation of feeding, drinking and gnawing following microinjections of muscimol into the medial raphe nucleus of rats. Behav. Neural Biol. 51, 436.
7. Lister, R.G., 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92, 180.
8. Lòpez-Rubalcava, C., Said var, A., Fernandez-Guasti, A., 1992. Interaction of GABA and serotonin in the anxiolytic action of diazepam and serotoninergic anxiolytics. Pharmacol. Biochem. Behav. 43, 433.
9. 2 opioid binding in the mouse central nervous system. Brain Res. 360, 117.
10. 3H]flunitrazepam binding in vivo. Eur. J. Pharmacol. 120, 141.
11. Pan, Z.Z., Williams, J.T., Osborne, P.B., 1990. Opioid actions on single nucleus raphe magnus neurons from rat and guinea-pig in vitro. J. Physiol. (London) 427, 519.
12. Pesold, C., Treit, D., 1995. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res. 671, 213.
13. 1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanism of action?. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 17, 87.
14. Sesak, S.R., Pickel, V.M., 1995. Ultrastructural relationships between terminals immunoreactive for enkephalin, GABA, or both transmitter in the rat ventral tegmental area. Brain Res. 672, 261.
15. Sugita, S., North, R.A., 1993. Opioid actions on neurons of rat amygdala in vitro. Brain Res. 612, 151.